Jesper T. Andreasen

1.5k total citations
54 papers, 1.2k citations indexed

About

Jesper T. Andreasen is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Cognitive Neuroscience. According to data from OpenAlex, Jesper T. Andreasen has authored 54 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Cellular and Molecular Neuroscience, 22 papers in Molecular Biology and 9 papers in Cognitive Neuroscience. Recurrent topics in Jesper T. Andreasen's work include Neurotransmitter Receptor Influence on Behavior (26 papers), Receptor Mechanisms and Signaling (15 papers) and Nicotinic Acetylcholine Receptors Study (15 papers). Jesper T. Andreasen is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (26 papers), Receptor Mechanisms and Signaling (15 papers) and Nicotinic Acetylcholine Receptors Study (15 papers). Jesper T. Andreasen collaborates with scholars based in Denmark, United States and Australia. Jesper T. Andreasen's co-authors include John P. Redrobe, Ciarán Martin Fitzpatrick, Jesper L. Kristensen, Elsebet Ø. Nielsen, Darryl S. Pickering, Kim Henningsen, Ove Wiborg, J.P. Redrobe, Elena V. Bouzinova and David P.D. Woldbye and has published in prestigious journals such as Brain Research, Pharmacological Reviews and Journal of Medicinal Chemistry.

In The Last Decade

Jesper T. Andreasen

54 papers receiving 1.2k citations

Peers

Jesper T. Andreasen
Madeleine V. King United Kingdom
Jesper T. Andreasen
Citations per year, relative to Jesper T. Andreasen Jesper T. Andreasen (= 1×) peers Madeleine V. King

Countries citing papers authored by Jesper T. Andreasen

Since Specialization
Citations

This map shows the geographic impact of Jesper T. Andreasen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jesper T. Andreasen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jesper T. Andreasen more than expected).

Fields of papers citing papers by Jesper T. Andreasen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jesper T. Andreasen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jesper T. Andreasen. The network helps show where Jesper T. Andreasen may publish in the future.

Co-authorship network of co-authors of Jesper T. Andreasen

This figure shows the co-authorship network connecting the top 25 collaborators of Jesper T. Andreasen. A scholar is included among the top collaborators of Jesper T. Andreasen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jesper T. Andreasen. Jesper T. Andreasen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Andreasen, Jesper T., et al.. (2023). Chronic corticosterone improves perseverative behavior in mice during sequential reversal learning. Behavioural Brain Research. 450. 114479–114479. 4 indexed citations
2.
Andreasen, Jesper T., et al.. (2023). Relationship between two forms of impulsivity in mice at baseline and under acute and sub-chronic atomoxetine treatment. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 127. 110841–110841. 2 indexed citations
4.
Kristensen, Jesper L., et al.. (2022). Animal Behavior in Psychedelic Research. Pharmacological Reviews. 74(4). 1176–1205. 15 indexed citations
5.
Kristensen, Jesper L., et al.. (2020). Investigating the role of 5-HT2A and 5-HT2C receptor activation in the effects of psilocybin, DOI, and citalopram on marble burying in mice. Behavioural Brain Research. 401. 113093–113093. 45 indexed citations
6.
Andreasen, Jesper T., et al.. (2020). Sequential reversal learning: a new touchscreen schedule for assessing cognitive flexibility in mice. Psychopharmacology. 238(2). 383–397. 8 indexed citations
7.
Jensen, Anders A., Adam L. Halberstadt, Muhammad Chatha, et al.. (2020). The selective 5-HT2A receptor agonist 25CN-NBOH: Structure-activity relationship, in vivo pharmacology, and in vitro and ex vivo binding characteristics of [3H]25CN-NBOH. Biochemical Pharmacology. 177. 113979–113979. 22 indexed citations
8.
Dietz, Andrea, et al.. (2019). Effect of ADHD medication in male C57BL/6J mice performing the rodent Continuous Performance Test. Psychopharmacology. 236(6). 1839–1851. 31 indexed citations
9.
Kristensen, Jesper L., et al.. (2019). The 5-hydroxytryptamine 2A receptor agonists DOI and 25CN-NBOH decrease marble burying and reverse 8-OH-DPAT-induced deficit in spontaneous alternation. Neuropharmacology. 183. 107838–107838. 28 indexed citations
10.
Fitzpatrick, Ciarán Martin, Ulrik Gether, Thomas Habekost, et al.. (2017). Theory of Visual Attention (TVA) applied to mice in the 5-choice serial reaction time task. Psychopharmacology. 234(5). 845–855. 10 indexed citations
12.
13.
Thomsen, Morten S., et al.. (2016). Nicotinic Acetylcholine Receptors in the Pathophysiology of Al zheimer's Disease: The Role of Protein-Protein Interactions in Current and Future Treatment. Current Pharmaceutical Design. 22(14). 2015–2034. 13 indexed citations
14.
Pickering, Darryl S., et al.. (2016). Modelling affective pain in mice: Effects of inflammatory hypersensitivity on place escape/avoidance behaviour, anxiety and hedonic state. Journal of Neuroscience Methods. 262. 85–92. 24 indexed citations
15.
Andreasen, Jesper T., John P. Redrobe, Elsebet Ø. Nielsen, et al.. (2013). A combined α7 nicotinic acetylcholine receptor agonist and monoamine reuptake inhibitor, NS9775, represents a novel profile with potential benefits in emotional and cognitive disturbances. Neuropharmacology. 73. 183–191. 13 indexed citations
16.
Sørensen, Holger J., et al.. (2013). An association between autumn birth and clozapine treatment in patients with schizophrenia: A population-based analysis. Nordic Journal of Psychiatry. 68(6). 428–432. 8 indexed citations
17.
Madsen, Morten V., Linda Peacock, Thomas Werge, Maibritt B. Andersen, & Jesper T. Andreasen. (2010). Effects of cannabinoid CB1 receptor agonism and antagonism on SKF81297-induced dyskinesia and haloperidol-induced dystonia in Cebus apella monkeys. Neuropharmacology. 60(2-3). 418–422. 3 indexed citations
18.
Andreasen, Jesper T. & J.P. Redrobe. (2008). Nicotine, but not mecamylamine, enhances antidepressant-like effects of citalopram and reboxetine in the mouse forced swim and tail suspension tests. Behavioural Brain Research. 197(1). 150–156. 46 indexed citations
19.
Hansen, Henrik H., Jesper T. Andreasen, Pia Weikop, et al.. (2007). The neuronal KCNQ channel opener retigabine inhibits locomotor activity and reduces forebrain excitatory responses to the psychostimulants cocaine, methylphenidate and phencyclidine. European Journal of Pharmacology. 570(1-3). 77–88. 45 indexed citations
20.
Andreasen, Jesper T., et al.. (2005). Nicotine and clozapine selectively reverse a PCP-induced deficit of PPI in BALB/cByJ but not NMRI mice: Comparison with risperidone. Behavioural Brain Research. 167(1). 118–127. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026